SCHEMBL20732205

SCHEMBL20732205

CC(=O)c1sc2nc(C)sc2c1N

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.50
ALDH1A1 P00352 6/20 0.50
HPGD P15428 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
HTT P42858 2/20 0.50
MAPT P10636 7/20 0.47
ATM Q13315 5/20 0.47
SLC14A1 Q13336 1/20 0.44
MEN1 O00255 4/20 0.43
KMT2A Q03164 4/20 0.43
L3MBTL1 Q9Y468 2/20 0.40
GLA P06280 1/20 0.40
RAB9A P51151 2/20 0.40
MCL1 Q07820 2/20 0.40
MAPK1 P28482 2/20 0.39
TLR9 Q9NR96 1/20 0.39
NPC1 O15118 2/20 0.39
POLB P06746 1/20 0.39
THRB P10828 1/20 0.39
RECQL P46063 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20722729 0.86 PKM (0.40) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL20722528 0.81 KDM4E (0.54) KDM4EALDH1A1SMN1; SMN2HTTMAPT
SCHEMBL23938072 0.72 HSD17B10 (0.47) SMN1; SMN2MAPTL3MBTL1MAPK1LIMK1
SCHEMBL20731142 0.72 GAA (0.38) SMN1; SMN2MAPTMAPK1HSD17B10GAA
SCHEMBL27326539 0.71 ALDH1A1 (0.41) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL23938071 0.69 HSD17B10 (0.35) MAPTMAPK1HSD17B10GAA
SCHEMBL12562427 0.68 LIMK1 (0.77) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL19769230 0.67 KDM4E (1.00) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL20732017 0.67 KDM4E (0.60) KDM4EALDH1A1HPGDSMN1; SMN2HTT
SCHEMBL12562446 0.67 SLC14A1 (0.60) KDM4EALDH1A1HPGDSMN1; SMN2HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020033707-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2020-02-13 WO disclosed
WO-2019032863-A1 CARBOXAMIDES AS UBIQUITIN-SPECIFIC PROTEASE INHIBITORS FORMA THERAPEUTICS, INC. (US) 2019-02-14 WO disclosed